T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$1.82B |
| 2 |
Sea Limited
SE
|
+$1.38B |
| 3 |
Cisco
CSCO
|
+$1.16B |
| 4 |
Netflix
NFLX
|
+$1.14B |
| 5 |
Ingersoll Rand
IR
|
+$1.03B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.54B |
| 2 |
Amazon
AMZN
|
+$1.75B |
| 3 |
Amphenol
APH
|
+$1.65B |
| 4 |
KLA
KLAC
|
+$1.5B |
| 5 |
Xcel Energy
XEL
|
+$1.38B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.6% |
| 2 | Financials | 11.17% |
| 3 | Healthcare | 11.1% |
| 4 | Communication Services | 10.25% |
| 5 | Consumer Discretionary | 10.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OPLN
1576
Openlane
OPLN
$4.28B
| $3.52M | ﹤0.01% |
120,844
+18,149
| +18% | +$524K |
|
1577
Cactus
WHD
$3.69B
| $3.52M | ﹤0.01% |
74,354
+11,012
| +17% | +$578K |
|
1578
Corcept Therapeutics
CORT
$10.1B
| $3.49M | ﹤0.01% |
86,590
-297,656
| -77% | -$11.1M |
|
1579
M/I Homes
MHO
$3.89B
| $3.49M | ﹤0.01% |
28,490
+4,139
| +17% | +$557K |
|
1580
10x Genomics
TXG
$5.97B
| $3.47M | ﹤0.01% |
163,215
+44,844
| +38% | +$896K |
|
1581
International Seaways
INSW
$4.64B
| $3.45M | ﹤0.01% |
47,324
+8,784
| +23% | +$562K |
|
1582
Viking Therapeutics
VKTX
$3.93B
| $3.43M | ﹤0.01% |
105,487
+14,264
| +16% | +$458K |
|
1583
Remitly
RELY
$4.91B
| $3.43M | ﹤0.01% |
218,902
+29,657
| +16% | +$439K |
|
1584
First Financial Bancorp
FFBC
$3.54B
| $3.43M | ﹤0.01% |
123,019
+17,530
| +17% | +$489K |
|
1585
Standex International
SXI
$3.55B
| $3.43M | ﹤0.01% |
13,449
+2,088
| +18% | +$524K |
|
1586
Brookfield Infrastructure
BIPC
$5.23B
| $3.43M | ﹤0.01% |
86,705
+17,356
| +25% | +$796K |
|
1587
Dropbox
DBX
$7.48B
| $3.42M | ﹤0.01% |
150,383
+7,069
| +5% | +$180K |
|
1588
Cathay General Bancorp
CATY
$4.25B
| $3.42M | ﹤0.01% |
68,519
+7,879
| +13% | +$398K |
|
1589
ING
ING
$95.1B
| $3.41M | ﹤0.01% |
130,787
+98,875
| +310% | +$2.78M |
|
1590
St. Joe Company
JOE
$3.57B
| $3.39M | ﹤0.01% |
53,904
+8,308
| +18% | +$556K |
|
1591
PennyMac Financial
PFSI
$4.45B
| $3.39M | ﹤0.01% |
38,737
-632,288
| -94% | -$68M |
|
1592
Park National Corp
PRK
$3.74B
| $3.38M | ﹤0.01% |
20,700
+3,393
| +20% | +$555K |
|
1593
Cushman & Wakefield Ltd
CWK
$3.2B
| $3.38M | ﹤0.01% |
275,640
-6,243,623
| -96% | -$89.5M |
|
|
BBT
1594
Beacon Financial Corp
BBT
$2.51B
| $3.38M | ﹤0.01% |
112,539
+7,321
| +7% | +$214K |
|
1595
Dolby
DLB
$4.97B
| $3.37M | ﹤0.01% |
56,057
-22,106
| -28% | -$1.4M |
|
1596
Minerals Technologies
MTX
$2.33B
| $3.36M | ﹤0.01% |
47,415
+5,845
| +14% | +$402K |
|
1597
Nicolet Bankshares
NIC
$3.65B
| $3.34M | ﹤0.01% |
22,495
+7,230
| +47% | +$1.05M |
|
1598
Twist Bioscience
TWST
$5.51B
| $3.34M | ﹤0.01% |
70,305
+11,320
| +19% | +$508K |
|
1599
iShares Russell 2000 Growth ETF
IWO
$14.4B
| $3.34M | ﹤0.01% |
10,638
-1,948
| -15% | -$648K |
|
1600
Cinemark Holdings
CNK
$4.1B
| $3.32M | ﹤0.01% |
116,298
+16,643
| +17% | +$426K |
|
Similar funds
T. Rowe Price Associates's Q1 2026 Portfolio in Review
As of Q1 2026, T. Rowe Price Associates held 3,202 positions worth $865B, down 6.7% from $927B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
T. Rowe Price Associates's Q1 2026 filing shows 115 new, 2,022 increased, 804 reduced and 71 closed positions. Its largest new stake was Cenovus Energy: 23,907,299 shares worth $634M. The largest sale was Microsoft, an estimated $3.54B.
By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q1 2026 buy was Cenovus Energy: 23,907,299 shares worth $634M.
- T. Rowe Price Associates added most to Advanced Micro Devices in Q1 2026, an estimated $1.82B increase.
- T. Rowe Price Associates's biggest Q1 2026 reduction was Microsoft, cutting an estimated $3.54B.
- T. Rowe Price Associates fully exited CyberArk in Q1 2026, selling an estimated $251M.
- T. Rowe Price Associates's ten largest holdings make up 34% of its $865B portfolio in Q1 2026.
- T. Rowe Price Associates opened 115 new positions and closed 71 in Q1 2026.
- T. Rowe Price Associates's portfolio value fell 6.7% quarter-over-quarter to $865B.
Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.